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INTRODUCTION
 Irritable bowel syndrome (IBS) is the most 
common, the most expensive, and the most 
disabling of functional gastrointestinal disorders. 
Its symptoms are abdominal pain or discomfort 
and change in bowel movement in the absence of 
diagnosable structural disorders.1,2
 The expression “quality of life” was primarily 
introduced into research after World War II with 
respect to patients with special diseases such as 
diabetes and AIDS, and specific disabilities.3,4 
A subset of quality of life called “health-related 
quality of life” (HRQOL) has attracted the 
interest of researchers and therapists.5,6 HRQOL 
relates to patients’ perceptions and attitudes to 
aspects of life that are affected by their disease.7,8 
There is general and increasing agreement that 
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ABSTRACT
Objectives: This study investigated the psychometric characteristics (structural, concurrent 
and construct validity, and internal consistency) of the Persian version of the Irritable Bowel 
Syndrome Quality of Life (IBS-QOL) questionnaire, which is commonly used across cultures.
Methodology: One hundred twenty-six patients with irritable bowel syndrome (based on 
diagnosis by professional physicians and the Rome II criteria) were selected from patients 
referred to Alzahra and Noor Hospitals in Isfahan to complete the IBS-QOL questionnaire.
Results: Eight subscales of the questionnaire (sum score) had acceptable internal consistency 
coefficients (alpha for subscales: dysphoria, 0.88; interference with activity, 0.67; body image, 
0.72; health worry, 0.57; food avoidance, 0.52; social reaction, 0.71; sexual concern, 0.76; 
relationships; 0.62; and overall score, 0.93). In order to assess construct validity, groups of 
healthy persons (n = 40) and patients (n = 40) were selected. Results of an independent t-test 
showed a significant difference between the mean of overall score and all subscale scores 
(except body image subscale) of the two groups (P < 0.05). Pearson correlation coefficients 
showed that the questionnaire has significant concurrent validity (with respect to IBS-QOL-36) 
(P < 0.05).
Conclusion: The Persian version of IBS-QOL-34 is a valid and reliable instrument and is suitable 
for used in research and clinical trials.
KEY WORDS: Irritable bowel syndrome, Quality of life questionnaire, Structural validity, Internal 
consistency, Concurrent validity, Construct validity.
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Psychometric Characteristics of the Persian Version of IBS-QOL Questionnaire
components of therapy and research effort. In 
the case of functional gastrointestinal disorders, 
because there are no specific symptoms and signs, 
assessment of HRQOL is particularly important 
for the determination of treatment responses and 
capturing the patients’ physical, psychological, and 
social functions7-9 In IBS, a chronic disease, quality 
of life is low and various dimensions of life, such as 
job activities, traveling, interpersonal relationships, 
and enjoyment, are disrupted.10-13
 In recent years researchers and professionals 
have shown a particular interest in the assessment 
of quality of life in IBS patients.14-16 Since there is no 
specific biological marker and patients and their 
therapists have different opinions about the illness 
experience, the most important criterion to deter-
mine the level of recovery is assessment of quality 
of life by the patients themselves. This is only possi-
ble by using questionnaires with established valid-
ity and reliability and sensitivity to treatment.9
 In 1998, the first questionnaire about quality of 
life for IBS patients [the Irritable Bowel Syndrome 
Quality of Life (IBS-QOL) questionnaire] was 
published by Patrick and Drossman.5 Among 
existing instruments, Patrick and Drossman’s 
questionnaire has been rated as the most valid 
and reliable, and it has been translated into over 
24 languages. The validity and reliability of the 
European and Asian versions of this questionnaire 
attest to its value as an international and 
intercultural instrument.17-19 Following the WHO 
method, this questionnaire is based on a needs-
oriented model in which quality of life is assessed 
as the extent to which patients’ needs are satisfied.20 
The development of this questionnaire was based on 
standard principles of psychometric design using 
established methodology.17 Quality of life advisers 
and gastroenterologist from England, Germany, 
Italy, and France cooperated in the construction of 
this questionnaire.21 In exploratory factor analysis of 
the final version of the questionnaire, eight factors 
are clearly distinguishable: dysphoria, relationships, 
sexual concern, health worry, social reaction, body 
image, food avoidance, and interference with 
activity. The main questionnaire and its European 
and Asian versions have always had high internal 
consistency and test–retest reliability, and special 
sensitivity and responsiveness to various treatments 
(medical and psychological therapies).17,18
 The aim of this study was to investigate the psy-
chometric characteristics (structural, concurrent, 
and construct validity and internal consistency) of 
the Persian version of this questionnaire in order to 
utilize this new version in further research in this 
country. We therefore tested two major hypotheses:
1. The Persian version of IBS-QOL has an 
acceptable and desirable internal structure, 
internal consistency, and construct validity.
2. The Persian version of IBS-QOL has significant 
concurrent and construct validity.
METHODOLOGY
Participants and procedures: The study population 
included all patients with IBS in Isfahan who were 
referred to professional medical centers. The mean 
age of the patients was 32.34 years (range 18–57 
years). First, two skilled translators (two profes-
sors from the foreign language faculty of Isfahan 
University) with the collaboration a gastroenterolo-
gist from Isfahan Medical University (to check the 
translation of medical expressions) translated the 
original version of IBS-QOL to Farsi and an agreed 
version of the translation was developed. Then, a 
native speaker of English, also fluent in Farsi, back-
translated it into English. By comparison with for-
ward translation, discrepancies and inaccuracies 
were removed. Then, a professor from the Persian 
literature faculty of Isfahan University corrected 
and confirmed the punctuation of the translation 
and a final Persian version of the questionnaire (P-
IBS-QOL) was prepared.
 Fundamental principles (including backward 
and forward translation and removal of grammati-
cal and structural mistakes) were taken into con-
sideration. The face validity of the questionnaire 
was evaluated before the subjects were asked to 
complete the questionnaire. Ten IBS patients were 
asked to highlight items that were vague or ambig-
uous. These items were then restructured by two 
professors of literature from Isfahan University. 
The 10 patients were then re-interviewed to assure 
the clarity of rectified items, in order to confirm face 
validity.
 Finally, questionnaires were distributed to focus 
groups. One hundred thirty patients (74 females 
and 56 males) who were referred to clinics of the 
Alzahra and Noor hospitals and were diagnosed 
with IBS based on the Rome II criteria and clinical 
and par clinical tests, and who were willing to 
participate in the study, were selected and asked 
to complete the Persian translation of IBS-QOL-34 
[one criterion was considered in order to select 
the sample: patients with no other gastrointestinal 
disease (the questionnaire was developed only for 
IBS patients)]. Four patients who did not respond 
completely to the questionnaire (more than four 
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items) were omitted from the research sample and 
the final sample comprised 126 participants.
 To assess concurrent validity, we needed an 
instrument that was known to measure QOL 
accurately and specifically for IBS patients. For 
this purpose, we selected IBS-QOL-36, which 
was developed and validated by Groll and 
colleagues. This questionnaire is a condition-
specific instrument that was developed according 
to systematic and standard methodology and 
has acceptable psychometric characteristics (see 
Measures). We translated this questionnaire into 
Persian and administered it to 40 IBS patients. 
The results showed that the scale has high internal 
consistency (0/87). Then, 44 of the patients from the 
sample were asked to complete IBS-QOL-34 and 
IBS-QOL-36 (whose validity was also established). 
 To determine the construct validity of the ques-
tionnaire, 40 people who had no history of gastroen-
terological disorders were selected to complete the 
quality of life questionnaire. They were 40 employ-
ees of Isfahan University and were selected because 
they had no records of gastrointestinal diseases in 
the medical files of the health center of Isfahan Uni-
versity, and currently they had no symptoms of any 
other chronic medical diseases (which might have a 
negative effect in HRQOL).
Ethics Approval: This study was approved by the 
ethics committee of the Alzahra General Hospital, 
Isfahan, Iran. An educational book about IBS (about 
the etiology and management of the disease, avail-
able at Tehran Medical University) was given to the 
patients to acknowledge their participation in the 
study.
Measures: The IBS-QOL-34 was developed in 1998 
by Patrick and Drossman to assess HRQOL for IBS 
patients. This questionnaire has special sensitivity 
to various treatments; it has been translated into 
several languages and the translated versions are 
valid and reliable.17,18 This questionnaire includes 
34 items scored on a five-point Likert scale (not at 
all, 1; slightly, 2; moderately, 3; quite a bit, 4; ex-
tremely, 5).5 This questionnaire has eight subscales: 
dysphoria, relationships, sexual concern, health 
worry, social reaction, body image, food avoidance, 
and interference with activity. Internal consistency 
coefficients of these subscales were 0.86, 0.83, 0.56, 
0.94, 0.76, 0.48, 0.61, and 0.74, respectively and that 
of the overall scale was 0.94.21
 The IBS-QOL-36, which was used in this 
research to assess the concurrent validity of the 
main questionnaire, was constructed by Groll et al 
in 2002 and includes 36 items scored on a seven-
point Likert scale. The items of IBS-QOL-36 were 
developed using the Medline database and about 
irritable bowel syndrome, quality of life, physical 
symptoms and existed questionnaires. The content 
validity is confirmed by an expert panel of nine 
gastroenterologists. This instrument has desirable 
psychometric properties. The internal consistency 
is 0.95 and its test–retest reliability is 0.92. This 
questionnaire was constructed after literature 
review and the validity of the instrument and its 
responsiveness to treatment is also established.9
Data Analysis: The data were analyzed using SPSS 
software (version 15). To analyze the psychometric 
characteristics of the questionnaire, we used Cron-
bach’s alpha (to assess coordination of items to as-
sess construct), structural validity (correlations of 
item subscales with items overall), concurrent valid-
ity (which showed the P-IBS-QOL assess construct 
of HRQOL, which was analyzed using Pearson cor-
relations), and an independent t-test (to determine 
construct validity). Before using the tests, we tested 
two preassumptions: 1) normality was tested with 
the Shapiro–Wilk test, and the results confirmed 
this preassumption (P > 0.05); 2) To assess the va-
lidity of using the independent t-test, we tested the 
equality of variances between two groups; the re-
sults did not show a significant difference between 
the scores of the two groups (P > 0.05).
RESULTS
 Demographic and clinical characteristics of the 
participants are presented in Table-I. Descriptive 
statistics (mean and standard deviation of raw 
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Table-I: Characteristics of study participants.
Variable Levels Frequency Percentage
Gender Male 55 43
 Female 71 57
Marital status Single 42 33
 Married 84 67
Education Lower than 31 25
   high school
 High school 57 45
   diploma
 College degree 11 9
 Bachelor’s degree 27 21
   and higher
Subtype Constipation 42 33
   predominant
 Diarrhea 51 40
   predominant
 Mixed 33 27
Severity Mild 49 39
 Average 57 45
 Severe 20 16
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scores) and correlation coefficients of each item and 
its subscales and for the overall test are presented in 
Table-II. The results show that most item–subscale 
correlations exceeded 0.55, and item–overall 
correlations exceeded 0.35 (with the exception of 
correlation coefficients of items 11, 21, and 32).
 The internal consistency coefficients of the eight 
subscales and the overall scale are presented 
in Table-III. With regard to concurrent validity 
between the main questionnaire and the other 
questionnaires whose psychometric characteristics, 
the correlation coefficient was 0.61, significant at 
the 0.01 level, and the questionnaire had acceptable 
concurrent validity (r = 0.61, P < 0.05).
 In order to assess the construct validity of the 
quality of life questionnaire, raw scores of the eight 
subscales and the total score of the questionnaire 
for the patients (n = 40) and healthy participants (n 
= 40) were compared using the independent t-test. 
The results showed significant differences between 
the mean raw scores for seven subscales (the excep-
tion was the body image subscale) and the overall 
scale for the two groups (P < 0.05). The results are 
presented in Table-IV.
DISCUSSION
 The IBS-QOL-34 was developed in 1998 by Patrick 
and Drossman and has special sensitivity to various 
treatments; it has been translated into several lan-
guages and the translated versions are valid and re-
liable. To prepare a Persian version of IBS-QOL, we 
translated the original questionnaire into Persian 
and tested its validity and internal consistency.
 We look first at the relationships of the items with 
the subscales and total scores. The magnitudes of 
the correlations showed that most item–subscale 
correlations exceeded 0.55 (i.e., almost 0.6, which is 
a satisfactory correlation). Item 20 had the highest 
correlation and item 31 had the lowest. Thus, most 
correlations were significant, which means that the 
Psychometric Characteristics of the Persian Version of IBS-QOL Questionnaire
Table-II: Review of descriptive findings on 
the scale and internal consistency of the items.
Domain Mean and Items Correlation Correlation
	 standard	 	 coefficient		 coefficient
 deviation  of subscales of overall 
           scale
Dysphoria 61.8 (25) 1 *0.59 *0.49
  6 *0.82 *0.53
  7 *0.70 *0.48
  9 *0.75 *0.62 
  10 *0.64 *0.64
  16 *0.65 *0.61
  30 *0.56 *0.50
Interference 67.8 3 *0.32 *0.24
 with activity (19.8) 18 *0.46 *0.48
  19 *0.46 *0.25
  22 *0.42 *0.39
  27 *0.36 *0.35
  29 *0.48 *0.28
  31 *0.17 *0.52
Sexual  73.5 (25) 12 *0.85 *0.36
  concern  20 *0.92 *0.28
Health worry 60.3 (25.5) 4 *0.60 *0.40
  15 *0.44 *0.43
  32 *0.53 *0.59
Food 42.6 (24.6) 11 *0.66 0.10
  avoidance  23 *0.49 *0.37
  28 *0.34 *0.18
Social reaction 44 (27.8) 2 *0.56 *0.39
  14 *0.71 *0.50
  17 *0.62 *0.38
  34 *0.84 *0.49
Relationships 42.6 (24.6) 8 *0.58 *0.46
  24 *0.69 *0.27
  33 *0.64 *0.88
Body image 28.2 (21.3) 5 *0.62 *0.31
  21 *0.47 0.11
  25 *0.80 *0.38
  26 *0.68 *0.74
Total score 40.4 (12.3)   
*Significant coefficients (P < 0.05)
Table-III: Internal consistency indices (Cronbach’s alpha) of subscales and overall scale in the 
Persian, American, European, and Japanese versions of IBS-QOL.
Domain Persian version American version European version Japanese version
Subscales (n = 126) (n = 155) (n = 35) (n = 49)
Dysphoria 0.88 0.92 0.94 0.94
Interference with activity 0.67 0.84 0.82 0.86
Body image 0.72 0.75 0.79 0.56
Health worry 0.57 0.70 0.74 0.48
Food avoidance 0.52 0.76 0.83 0.83
Social reaction 0.71 0.74 0.84 0.76
Sexual 0.76 0.83 0.75 0.61
Relationships 0.62 0.65 0.77 0.74
Overall scale 0.93 0.95 0.96 0.96
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items show an acceptable statistical relationship. 
Another important finding is that the item–sub-
scale correlations were higher than the item–overall 
correlations. This is an acceptable finding, meaning 
that in general the questionnaire has a desirable 
consistency and internal structure.
 To assess the internal consistency of the subscales, 
we used Cronbach’s alpha. The subscale food 
avoidance had the lowest internal consistency (0.52) 
and dysphoria the highest (0.88). The minimum 
alpha considered acceptable for questionnaire 
validation is 0.7.22 Cronbach’s alpha for subscale 
relationships, health worry, food avoidance, and 
interference with activity was lower than the 
acceptable value of 0.7. This may be explained by 
the lower conceptual relationships of these subscale 
items compared with other subscales. This result 
is consistent with the results of Kanazawa17 and 
Patrick and Drossman.21 However, the subscale of 
health worry in the Persian, American, European, 
and Japanese versions of the questionnaire had 
a low alpha. This may be related to the content 
of questions on this subscale, which could be 
replaced by ideas expressed by these patients 
regarding their health, such as “this disease leads 
to progressive complications and brings my death 
closer” or “this disease will never be treated” (only 
in Persian culture). This finding is understandable 
in light of the equation for Cronbach’s alpha 















). The magnitude of 
Cronbach’s alpha has a direct relationship with 
the number of items; therefore, the dysphoria 
subscale (with eight items) has a higher alpha 
than the food avoidance subscale (three items). In 
the American, European, and Japanese versions 
of IBS-QOL, the dysphoria subscale has the 
highest alpha (Table-III).
 Moreover, the high internal consistency coef-
ficients of the dysphoria subscale and the overall 
questionnaire (sum score) supports the idea that 
Cronbach’s alpha is greatly affected by the number 
of questions in a questionnaire. An absolute con-
clusion cannot be made by comparing the internal 
consistency indices of the Persian, American, Eu-
ropean, and Japanese versions. In the Persian ver-
sion, the food avoidance subscale has the lowest 
internal validity, while in the American, European, 
and Japanese versions the relationship and health 
worry subscales have the lowest internal validity; 
however, the internal consistency of the question-
naire is acceptable and relatively high.
 Quality of life is a complicated concept which 
is affected by social and cultural factors. Social 
reactions of people around patients towards their 
complaints, patients’ attitudes, and body image 
and the effects of disease on body image are 
greatly influenced by the social culture and its 
values and norms. To assess concurrent validity, 
a completely specific instrument (rather than a 
general instrument) was needed. For this purpose 
we selected IBS-QOL-36, which was developed 
and validated by Groll and colleagues. These 
two questionnaires overlap in some dimensions 
and constructs. The questionnaire was translated 
and administered to 40 IBS patients. The results 
showed that the scale has high internal consistency 
(0/87). Assessment of concurrent validity showed a 
significant and relatively high positive correlation 
coefficient between the two questionnaires, which 
means that this instrument can be used safely for 
assessing quality of life.
 The results of the construct validity assessment 
showed that the questionnaire items specifically 
assess patients’ problems in daily life. This means 
that the questions are designed with special 
consideration of the patients’ specific problems.
 In another study, the construct validity of 
this questionnaire was confirmed in distinction 
between the quality of life of IBS patients and 
patients with other gastroenterological disorders.10 
Indeed, using this instrument for full diagnosis 
needs determination of the optimal cut-off point as 
well as its specificity and sensitivity. Factor analysis 
(the KMO coefficient was not satisfied) was not 
used in this research. It is recommended that future 
research in this field should use confirmatory factor 
analysis (CFA) to assess the construct validity and 
subscales of the questionnaire.
Limitation and recommendation: Because of time 
limitation it was not possible to determine the 
Table-IV: Results of independent t-test assessing
the construct validity of IBS-QOL of in
healthy participants and patients.
Subscales	 Mean	difference	 Significance	level
Dysphoria 7.55 0.000*
Body image 3.27 0.002*
Food avoidance 1.49 0.087
Sexual 2.85 0.000*
Relationships 4.87 0.000*
Interference with activity 2.15 *0.021
Health worry 2.03 *0.034
Social reaction 3.62 *0.000
Overall scale 28 *0.000
*Significant difference (P < 0.05)
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test–retest reliability and responsiveness to treat-
ment of P-IBS-QOL. However, one doctoral thesis 
(from the psychology department of Isfahan Uni-
versity), titled “The efficacy of relaxation therapy, 
cognitive-behavioral therapy and life style training 
on the HRQOL of IBS patients” used P-IBS-QOL 
as an instrument, and the results of MANCOVA 
showed significant differences between four exper-
imental groups and a control group.23 This means 
P-TBS-QOL has adequate sensitivity to therapeutic 
changes. We suggest that the test–retest reliability 
of P-IBS-QOL should be determined at different in-
tervals in the next validation of this version. Also, 
experimental plans must be designed to consider 
the rate of responsiveness of IBS-QOL to therapeu-
tic interventions such as drug therapy, CBT, and 
psychoeducation. Another limitation of this study 
was that although we tried to select the research 
sample with regard to the age range and gender 
distribution of the population, because of the high 
prevalence of IBS the sample size was relatively 
small. This factor must be considered in future 
research on this version of the questionnaire.
CONCLUSION
 In conclusion, the P-IBS-QOL appears to be a 
valid and reliable scale that can be used to assess 
QOL specifically in IBS patients in the Persian 
population. This version of IBS-QOL has an 
acceptable and desirable internal structure, internal 
consistency, and construct validity. P-IBS-QOL can 
be used in clinical and research trails.
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